Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy

Hiromi Inoue, Sung Hee Hwang, Aaron T. Wecksler, Bruce D. Hammock, Robert H Weiss

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib attenuates p21 in kidney cancer cells and augments cell death in combination with DNA-damaging chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences